BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Glaxosmithkline Pharmaceuticals Ltd Industry :  Pharmaceuticals - Multinational
BSE Code
500660
ISIN Demat
INE159A01016
Book Value (Rs)
132.2958859
NSE Symbol
GLAXO
Divident Yield %
2.69
Market Cap
(Rs In Cr.)
35,926
P/E (TTM)
39.57
EPS (TTM)
53.59
Face Value
(Rs)
10
Date Heading
14-May-26 GSK Pharma gains as Q4 PAT rises 6% YoY to Rs 275 cr
13-May-26 GlaxoSmithKline Pharmaceuticals to hold AGM
13-May-26 Board of GlaxoSmithKline Pharmaceuticals recommends Final Dividend
13-May-26 Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in
13-May-26 GSK Pharma Q4 PAT rises 6% YoY to Rs 275 cr
22-Apr-26 GlaxoSmithKline Pharmaceuticals to announce Quarterly Result
21-Apr-26 Glaxosmithkline appoints Vinay Subramanian as Commercial Head – Oncolo
09-Feb-26 Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% i
07-Jan-26 GlaxoSmithKline Pharmaceuticals to table results
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)